136 related articles for article (PubMed ID: 7138588)
1. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets.
Lampugnani MG; de Gaetano G
Biochem Pharmacol; 1982 Sep; 31(18):3000-2. PubMed ID: 7138588
[No Abstract] [Full Text] [Related]
2. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
Bevan J; Heptinstall S
Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
[TBL] [Abstract][Full Text] [Related]
3. Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation.
Karasawa A; Kubo K; Shuto K; Nakamizo N
Jpn J Pharmacol; 1985 Mar; 37(3):285-91. PubMed ID: 3158769
[TBL] [Abstract][Full Text] [Related]
4. Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human platelets in vitro.
De Clerck F; Xhonneux B
Agents Actions; 1986 Mar; 17(5-6):515-26. PubMed ID: 2939698
[TBL] [Abstract][Full Text] [Related]
5. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
Williams BC; Shaikh S; Edwards CR
J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
[TBL] [Abstract][Full Text] [Related]
6. Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in humans.
De Clerck F; Xhonneux B
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S23-5. PubMed ID: 2412050
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
Buczko W; Gambino MC; De Gaetano G
Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
de Clerck F; David JL; Janssen PA
Agents Actions; 1982 Jul; 12(3):388-97. PubMed ID: 6215842
[TBL] [Abstract][Full Text] [Related]
9. Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserin.
De Clerck F; Van Nueten JM
Thromb Res; 1982 Sep; 27(6):713-27. PubMed ID: 6817452
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of platelet mobilisation into lungs in response to 5-hydroxytryptamine (serotonin) in mice.
Yu Z; Ohba M; Nakamura M; Sasano T; Ono M; Sugawara S; Endo Y
Thromb Haemost; 2009 Dec; 102(6):1251-8. PubMed ID: 19967158
[TBL] [Abstract][Full Text] [Related]
11. Role of serotonin in patients with acute respiratory failure.
Huval WV; Lelcuk S; Shepro D; Hechtman HB
Ann Surg; 1984 Aug; 200(2):166-72. PubMed ID: 6547816
[TBL] [Abstract][Full Text] [Related]
12. Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat platelets.
Pietraszek MH; Buczko W
Eur J Pharmacol; 1987 Jun; 137(2-3):273-5. PubMed ID: 3609146
[TBL] [Abstract][Full Text] [Related]
13. Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.
Conn PJ; Sanders-Bush E
Neuropharmacology; 1984 Aug; 23(8):993-6. PubMed ID: 6483122
[TBL] [Abstract][Full Text] [Related]
14. Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failure.
Grobecker H; Gessler I; Delius W; Dominiak P; Kees F
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S102-4. PubMed ID: 2412024
[TBL] [Abstract][Full Text] [Related]
15. Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets.
Affolter H; Burkard WP; Pletscher A
Eur J Pharmacol; 1985 Jan; 108(2):157-62. PubMed ID: 3156755
[TBL] [Abstract][Full Text] [Related]
16. The 5-hydroxytryptamine receptor of blood platelets.
Pletscher A; Affolter H
J Neural Transm; 1983; 57(4):233-42. PubMed ID: 6655466
[TBL] [Abstract][Full Text] [Related]
17. Peripheral serotonin2 receptor blockade does not inhibit 5-hydroxytryptophan-induced aldosterone stimulation.
Shenker Y; Gross MD; Grekin RJ
J Clin Endocrinol Metab; 1985 Dec; 61(6):1201-4. PubMed ID: 2932460
[TBL] [Abstract][Full Text] [Related]
18. Differential large and small vessel responses to serotonin in the dog hindlimb in vivo: role of the 5HT2 receptor.
Blackshear JL; Orlandi C; Garnic JD; Hollenberg NK
J Cardiovasc Pharmacol; 1985; 7(1):42-9. PubMed ID: 2580149
[TBL] [Abstract][Full Text] [Related]
19. Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.
Wielosz M; Salmona M; de Gaetano G; Garattini S
Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):59-65. PubMed ID: 1012348
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of action of ketanserin, a selective antagonist of the S2 receptors with antihypertensive activity.
Rión R; Mena MA; Hong E
Proc West Pharmacol Soc; 1983; 26():373-5. PubMed ID: 6889366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
